Ferredoxin reductase: Pharmacogenomic assessment in colorectal cancer

Cancer Research

Volumn 63, Issue 19, 2003, Pages 6170-6173

  Yu, Jinsheng ^a   Marsh, Sharon ^a   Ahluwalia, Ranjeet ^a   McLeod, Howard L ^a,b  

^a USA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERREDOXIN; FERREDOXIN OXIDOREDUCTASE; FLUOROURACIL; OXIDOREDUCTASE; RNA; TAQ POLYMERASE; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FERREDOXIN-NADP REDUCTASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, NEOPLASM;

EID: 0141954046     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Longley, D. B., Harkin, D. P., and Johnston, P. G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer, 3: 330-338, 2003.
2. Kurtz, J. E., Andres, E., Natarajan-Ame, S., Noel, E., and Dufour, P. Oral chemotherapy in colorectal cancer treatment: review of the literature. Eur. J. Intern. Med., 14: 18-25, 2003.
3. Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A., Kinzler, K. W., and Vogelstein, B. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat. Med., 7: 1111-1117, 2001.
4. Liu, G., and Chen, X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene, 21: 7195-7204, 2002.
5. Muller, J. J., Lapko, A., Bourenkov, G., Ruckpaul, K., and Heinemann, U. Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem., 276: 2786-2789, 2001.
6. Hanukoglu, I., Rapoport, R., Weiner, L., and Sklan, D. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system. Arch. Biochem. Biophys., 305: 489-498, 1993.
7. Rapoport, R., Sklan, D., and Hanukoglu, I. Electron leakage from the adrenal cortex mitochondial P450scc and P450c11 systems: NADPH and steroid dependence. Arch. Biochem. Biophys., 317: 412-416, 1995.
8. McLeod, H. L., and Yu, J. Cancer pharmacogenomics: SNPs, chips, and the individual patient. Cancer Investig., 21: 628-638, 2003.
9. Watters, J. W., and McLeod, H. L. Cancer pharmacogenomics: current and future applications. Biochem. Biophys. Acta, 1603: 99-111, 2003.
10. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29: 2002-2007, 2001.
11. Shirota, Y., Stoehlmacher, J., Brabender, J., Xiong, Y. P., Uetake, H., Danenberg, K. D., Groshen, S., Tsao-Wei, D. D., Danenberg, P. V., and Lenz, H. J. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J. Clin. Oncol., 19: 4298-4304, 2001.
12. Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., Cook, B. P., Dufault, M. R., Ferguson, A. T., Gao, Y., He, T. C., Hermeking, H., Hiraldo, S. K., Hwang, P. M., Lopez, M. A., Luderer, H. F., Mathews, B., Petroziello, J. M., Polyak, K., Zawel, L., Zhang, W., Zhang, X., Zhou, W., Haluska, F. G., Jen, J., Sukumar, S., Landes, G. M., Riggins, G. J., Vogelstein, B., and Kinzler, K. W. Analysis of human transcriptomes. Nat. Genet., 23: 387-388, 1999.
13. Marsh, S., Kwok, P., and McLeod, H. L. SNP databases and pharmacogenetics: great start but a long way to go. Hum. Mutat., 20: 174-179, 2002.
14. Ronaghi, M. Pyrosequencing sheds light on DNA sequencing. Genome Res., 11: 3-11, 2001.
15. Schaid, D. J., McDonnell, S. K., Wang, L., Cunningham, J. M., and Thibodeau, S. N. Caution on pedigree haplotype inference with software that assumes linkage equilibrium. Am. J. Hum. Genet., 71: 992-995, 2002.
16. Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem., 274: 36031-36034, 1999.
17. Unger, T., Sionov, R. V., Moallem, E., Yee, C. L., Howley, P. M., Oren, M., and Haupt, Y. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene, 18: 3205-3212, 1999.
18. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Wash. DC), 266: 807-810, 1994.
19. LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., and Ashkenazi, A. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat. Med., 8: 274-281, 2002.
20. Lee, J. M. Inhibition of TP53-dependent apoptosis by the KIT tyrosine kinase: regulation of mitochondrial permeability transition and reactive oxygen species generation. Oncogene, 17: 1653-1662, 1998.
21. Li, P. F., Dietz, R., and von Harsdorf, R. TP53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J., 18: 6027-6036, 1999.
22. Violette, S., Poulain, L., Dussaulx, E., Pepin, D., Faussat, A. M., Chambaz, J., Lacorte, J. M., Staedel, C., and Lesuffleur, T. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and TP53 status. Int. J. Cancer, 98: 498-504, 2002.
23. Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K., Arnold, K., Ruano, G., and Liggett, S. B. Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. USA, 97: 10483-10488, 2000.